Re: Biparametric vs Multiparametric MRI for Prostate Cancer Diagnosis. The PRIME Diagnostic Clinical Trial.

Pattou M; Peyrottes A; Long-Depaquit T; Tokarski E; Baboudjian M

doi:10.1016/j.eururo.2025.11.018

← 뒤로

Re: Biparametric vs Multiparametric MRI for Prostate Cancer Diagnosis. The PRIME Diagnostic Clinical Trial.

0/5 보강

European urology 📖 저널 OA 5.1% 2021~2026 2026 Vol.89(3) p. 291-292

Pattou M, Peyrottes A, Long-Depaquit T, Tokarski E, Baboudjian M

PubMed ↗ DOI ↗ BibTeX ↓ RIS ↓

이 논문을 인용하기

↓ .bib ↓ .ris

APA Pattou M, Peyrottes A, et al. (2026). Re: Biparametric vs Multiparametric MRI for Prostate Cancer Diagnosis. The PRIME Diagnostic Clinical Trial.. European urology, 89(3), 291-292. https://doi.org/10.1016/j.eururo.2025.11.018

MLA Pattou M, et al.. "Re: Biparametric vs Multiparametric MRI for Prostate Cancer Diagnosis. The PRIME Diagnostic Clinical Trial.." European urology, vol. 89, no. 3, 2026, pp. 291-292.

PMID 41381295 ↗

DOI 10.1016/j.eururo.2025.11.018

같은 제1저자의 인용 많은 논문 (1)

Evaluating the Safety of Delaying Surgery Beyond 9 Months in Localized Prostate Cancer Patients: Results From a Prospective Study With Propensity Score Matching.
International journal of urology : official journal of the Japanese Urological Association 2025